INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 March 2012
|
Total net assets |
£118.8m |
|
NAV per share |
214.3p |
|
Share price |
183.5p |
|
Total value of unquoted investments |
£19.0m |
|
Total number of portfolio companies |
66 |
|
Cash |
9% NAV |
|
Cash committed and reserved to unquoted investments |
(8)% NAV |
|
Portfolio companies with < 1 year of cash |
8.18% NAV |
Top Ten Holdings
|
Company Name |
% NAV |
|
Celgene Amgen |
4.8 4.7 |
|
Pharmaxis Teva |
4.0 3.9 |
|
Alexion |
3.8 |
|
Insulet |
3.5 |
|
Biogen Gilead Aptiv Solutions |
3.3 2.9 2.7 |
|
Illumina |
2.6 |
|
|
----------- |
|
Total |
36.2 |
|
Geographical Allocation |
% |
|
United States & Canada |
70 |
|
Europe |
13 |
|
Australia |
4 |
|
Israel |
4 |
|
Cash |
9 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted allocation |
% |
|
Quoted |
75 |
|
Unquoted |
16 |
|
Cash |
9 |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
19 APRIL 2012